Ulthera, which sells ultrasound energy systems for non-invasive aesthetic procedures, formally withdrew its plans for an initial public offering on Tuesday. In late June, the company announced it would be acquired by Merz, a privately held pharmaceutical company specializing in medical and aesthetic dermatology and neurological movement disorders, for $600 million in upfront cash and milestone payments.
Help employers find you! Check out all the jobs and post your resume.
